Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition. - Wikidata - wikimedia - TriplyDB

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

http://www.wikidata.org/entity/Q36088183

about

Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer One mouse, one patient paradigm: New avatars of personalized cancer therapy Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinoma The future of patient-derived tumor xenografts in cancer treatment.Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine Targeting lung cancer through inhibition of checkpoint kinases.Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma Mechanisms of chemoresistance in cancer stem cells.Cancer stem cells and chemoresistance: The smartest survives the raid The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair.Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.Cancer subclonal genetic architecture as a key to personalized medicine.The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties.AMPK and Cancer.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non-small cell lung cancer.Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells.Wnt-driven intestinal tumourigenesis is suppressed by Chk1 deficiency but enhanced by conditional haploinsufficiency.Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells.

P2860

Q26740207-63FCA02A-0A8E-40A6-951B-1C2FFDE1D86D Q26776513-ADDB17AF-4D6B-4A7E-AB6D-52BA50A73E80 Q27023342-7B0FAD53-7ADE-4832-93BF-B84A7D383DC1 Q27330365-4BFB28AF-795B-4EC5-B58B-342A8474BBB4 Q28534618-8CBE8141-FDC7-43CD-AB6E-55883BDC8A5F Q33361578-8A13065B-B866-42CA-B849-48591D673C3F Q34067873-9B75C2E5-0140-43C7-883B-A156B2966F62 Q34154791-4D2035BE-7D4F-44A9-9A20-A76BBAB8841D Q35128547-7DF3B8D9-43A5-44BA-ABBD-0BAAB2564459 Q35444029-85496E95-2072-4A53-A775-04CDDFF7F5D5 Q36591484-1017B94E-6D65-42C8-AB14-18DAF34DC910 Q36730432-0C944F4B-8A4F-4393-BA2B-B6FD4C85DF9C Q36927012-A2BDD883-2622-42DE-B927-688B1749FA62 Q37362644-975DF6EE-041E-4C43-8D4F-A273B1FB9B22 Q37448116-253CCB93-43EB-4996-A977-F9B860AB4D82 Q38287226-51B9C894-77DE-4433-A2BB-DFE8437222F6 Q38324456-A02C0A9E-C12C-48A8-8FC4-2C8F97D00B63 Q38824383-B038E295-0DFA-4B04-A5E7-7C195D170CB5 Q38954172-28CEB34A-B1DF-43C6-A628-82981FD5A60A Q38998413-B699E308-F222-4172-9FDC-A9740577E771 Q39031410-704F3FB0-C0BB-4B1A-B614-801F91CA4911 Q39034833-2ACFC87A-9481-4289-8864-633FF93BB7D4 Q39204274-C80532AC-EEC0-4981-9724-C3C458F144C6 Q41470356-50444792-3943-4763-BBA0-7C450ABCE040 Q41879186-F533314F-DE2B-4717-9CB2-B45F93AD17C2 Q42092920-DD777A47-6B3D-4CE4-8165-FD78B1B1F487 Q44513883-BB22F2B6-2A89-418D-A9DC-58E1E34A0B72 Q48232893-AF4A9A8C-1CE8-4CB5-858C-652BD3113518

P2860

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

http://www.wikidata.org/entity/Q36088183

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

@ast

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

@en

type

label

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

@ast

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

@en

prefLabel

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

@ast

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

@en

P1433

Q36088183-C2FE4FB2-AE73-47ED-9DAF-56CD5A404B30

P1476

Q36088183-02CEA0A9-FF0D-4D64-99D3-73FF28FA8232

P2093

Q36088183-05D678B6-E5EA-457C-8319-E37C16A88550

Q36088183-3113D2CA-7D4C-4B13-9290-14E7DA442787

Q36088183-3742209F-22FA-4260-B5AF-466AA7E37593

Q36088183-65B36C9D-B084-44EA-9B65-724F3FCC07CD

Q36088183-6EE1C4D3-AC9E-4B9C-A7E9-4CC47D9F55B7

Q36088183-934321A3-F4FA-4F19-98EC-7FBACEB8C0B1

Q36088183-95C93AAD-0119-4DBF-AFBC-790CF40A4E2A

Q36088183-CB090801-ABFD-4D68-92AF-D2E4F6285BE5

Q36088183-E04F0809-FC64-4547-9592-AFF92D6ACF7D

P2860

Q36088183-02D091DB-4CC4-4F72-93E1-3034FC6369E4

Q36088183-031EF2E5-0A83-4302-B5B0-928561493F66

Q36088183-045F91A7-F28C-47F6-A1A8-C086E7531D49

Q36088183-05A7BF60-1B0D-4258-81DC-4FEB452041A2

Q36088183-0817E142-6550-4C78-828F-16E55243543C

Q36088183-0F607C26-C059-46BD-B778-F61C92BE1F3B

Q36088183-187C82B6-DD36-4141-A44A-D16C9B256017

Q36088183-2142C26B-1132-4605-BFA3-4254C93A12C7

Q36088183-22DD0451-7938-4DD0-A2C8-DE20E5E16A78

Q36088183-31109554-8DBD-4358-A39E-C8187A92D0A1

P304

Q36088183-4B1623A4-FB87-4429-8A27-42E86B7A6FFD

P31

Q36088183-F9F05E5A-A9A3-4EA8-8308-2A33AED72077

P356

Q36088183-436BF4BF-ADC4-4F7A-9A99-E96C878BE8A8

P433

Q36088183-577ECBF8-735B-47EB-958C-F39DC2ED7202

P478

Q36088183-053FA5E5-D1B5-4C8D-9E4F-BEAF854198B0

P577

Q36088183-2F0A8037-AF67-47AA-8ED4-64ECB5CA3786

P698

Q36088183-35CAD58E-D620-4212-B299-8BCEB67C02C8

P932

Q36088183-CA865A9D-7B1E-48EA-83C2-DA5DA7CAA550

P356

P1433

P1476

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition.

@en

P2093

Diane M Simeone

http://www.w3.org/2001/XMLSchema#string

Jonathan Maybaum

http://www.w3.org/2001/XMLSchema#string

Joshua D Parsels

http://www.w3.org/2001/XMLSchema#string

Leslie A Parsels

http://www.w3.org/2001/XMLSchema#string

Lili Zhao

http://www.w3.org/2001/XMLSchema#string

Meredith A Morgan

http://www.w3.org/2001/XMLSchema#string

Sonya D Zabludoff

http://www.w3.org/2001/XMLSchema#string

Theodore S Lawrence

http://www.w3.org/2001/XMLSchema#string

Venkatasubbaiah A Venkatesha

http://www.w3.org/2001/XMLSchema#string

P2860

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

Identification of pancreatic cancer stem cells

Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics

The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Association of reactive oxygen species levels and radioresistance in cancer stem cells

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

P304

519-525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.12538

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22787433

http://www.w3.org/2001/XMLSchema#string

P932

3394194

http://www.w3.org/2001/XMLSchema#string